Wei Lin
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
-
- Vasculitis and related conditions
- Ferroptosis and cancer prognosis
Papers in
-
- Vasculitis and related conditions 19
-
- Inflammasome and immune disorders 6
- RNA modifications and cancer 4
- Co-authors
- Mark A. White (1 shared paper)Xiaodong Cheng (1 shared paper)Zhijie Xu (7 shared papers)Yuanliang Yan (7 shared papers)Chunlin Ou (6 shared papers)Xiangcheng Xiao (23 shared papers)Ting Meng (20 shared papers)Yong Zhong (19 shared papers)
- Journals
- Clinical and Experimental Medicine (6 papers)Frontiers in Immunology (3 papers)Translational Pediatrics (2 papers)OncoTargets and Therapy (2 papers)Frontiers in Medicine (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Wei Lin
84 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Nephrology 110
- Pulmonary and Respiratory Medicine 238
- Infectious Diseases 114
- Immunology 126
- Molecular Biology 378
Countries citing papers authored by Wei Lin
This map shows the geographic impact of Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lin more than expected).
Fields of papers citing papers by Wei Lin
This network shows the impact of papers produced by Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lin. The network helps show where Wei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 115 | |
| 2 | 2019 | 86 | |
| 3 | 2019 | 40 | |
| 4 | 2020 | 38 | |
| 5 | 2020 | 34 | |
| 6 | 2020 | 32 | |
| 7 | 2021 | 31 | |
| 8 | Expression of inflammasomes NLRP1, NLRP3 and AIM2 in different pathologic classification of lupus nephritis. | 2020 | 31 |
| 9 | 2020 | 31 | |
| 10 | 2016 | 27 | |
| 11 | 2020 | 27 | |
| 12 | 2024 | 27 | |
| 13 | 2021 | 25 | |
| 14 | 2010 | 24 | |
| 15 | 2023 | 24 | |
| 16 | 2019 | 24 | |
| 17 | 2022 | 23 | |
| 18 | 2019 | 21 | |
| 19 | 2020 | 19 | |
| 20 | 2019 | 19 |
About Wei Lin
Wei Lin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Physiology and Epidemiology, having authored 97 papers that have together received 1.1k indexed citations. Recurring topics across this work include Vasculitis and related conditions (19 papers), Inflammasome and immune disorders (6 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers), Renal Diseases and Glomerulopathies (5 papers), COVID-19 Clinical Research Studies (4 papers), RNA modifications and cancer (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). The work is most often cited by research in Nephrology (110 citations), Pulmonary and Respiratory Medicine (238 citations), Infectious Diseases (114 citations), Immunology (126 citations) and Molecular Biology (378 citations). Wei Lin has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Mark A. White, Xiaodong Cheng, Zhijie Xu, Yuanliang Yan, Chunlin Ou, Xiangcheng Xiao, Ting Meng, Yong Zhong, Shuangshuang Zeng and Yu‐Qiu Zhang. Their work appears in journals such as Clinical and Experimental Medicine, Frontiers in Immunology, Translational Pediatrics, OncoTargets and Therapy and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.